Elsevier

Molecular Immunology

Volume 29, Issue 6, June 1992, Pages 739-749
Molecular Immunology

Specific histamine release capacity of peptides selected from the modelized der P I protein, a major allergen of Dermatophagoides pteronyssinus

https://doi.org/10.1016/0161-5890(92)90184-YGet rights and content

Abstract

Dust mite allergens are considered as a major cause of allergic disease and as a risk factor for asthma. Der p I, a 222 amino-acid residue globular glycoprotein, is one of the major allergens from Dermatophagoides pteronyssinus (Dpt) mites. In this study, we have used predictive conventional algorithms (i.e. hydrophilicity, mobility, accessibility) and a three-dimensional model of Der p I derived from comparison to actinidin and papain to select continuous amino acid sequences as potential B cell epitopes. Four peptides, 52–71, 117–133, 176–187, 188–199 were synthesized. Their antigenic reactivity was investigated, mainly by measuring their capacity to induce in vitro histamine release. Results indicated that only Dpt-sensitive patients react specifically to Der p I-derived peptides and more frequently to 52–71 and 117–133. For each peptide, the intensity of response was dependent on the patient tested and on the peptide concn. The capacity of peptides to induce histamine release was demonstrated to be correlated with the serum level of anti-Der p I IgE (r = 0.86; p < 10−2).

Taken together these data emphasize, in Dpt-sensitive patients, the heterogeneity of the specific response to synthetic Der p I-derived peptides and underline the possible variety of epitopes belonging to the allergen Der p I.

References (53)

  • G. Marone et al.

    Pathophysiology of human basophils and mast cells allergic disorders

    Clin. Immun. Immunopathol.

    (1989)
  • A.M. Morel et al.

    Immunoanalysis of histamine through a novel chemical derivatization

    J. Allergy Clin. Immun.

    (1988)
  • M. Mousli et al.

    G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides

    TIPS

    (1990)
  • T.A.E. Platts-Mills et al.

    Dust mites: Immunology, allergic disease, and environmental control

    J. Allergy Clin. Immunol.

    (1987)
  • D.C. Benjamin et al.

    The antigenic structure of protein

    Ann. Rev. Immun.

    (1984)
  • T.L. Blundell et al.

    Knowledge-based prediction of protein structure and the design of novel molecules

    Nature

    (1987)
  • A. Capron et al.

    Platelets in asthma

  • A. Capron et al.

    Platelets as effectors in immune and hypersensitivity reaction

    Int. Arch. Allergy Appl. Immun.

    (1987)
  • B. Casolaro et al.

    Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma

    Am. Rev. Resp. Dis.

    (1990)
  • M.D. Chapman et al.

    Measurement of IgG, IgA, and IgE partially purified fraction of mite extract (F4P1)

    Clin. Exp. Immun.

    (1978)
  • M.D. Chapman et al.

    Purification and characterization of the allergen from Dermatophagoides pteronyssinus-antigen PI

    J. Immun.

    (1980)
  • M.D. Chapman

    Monoclonal antibodies as structural probes for mite, cat, and cockroach allergens

    Adv. Biosciences

    (1989)
  • K.Y. Chua et al.

    Sequence analysis of cDNA coding for a major house dust mite allergen. Der pI

    J. exp. Med.

    (1988)
  • C. Chothia

    The nature of the accessible and buried surfaces in proteins

    J. molec. Biol.

    (1976)
  • E.J. Goetzl et al.

    A basophil activating factor from human T-lymphocytes

    Immunology.

    (1984)
  • W.A. Hook et al.

    Complement-induced histamine release from human basophils

    J. Immun.

    (1975)
  • Cited by (28)

    • In silico prediction of B-cell epitopes for twenty-five mite allergens: The therapeutic potentials for immunotherapy

      2019, Molecular and Cellular Probes
      Citation Excerpt :

      In our study, it was shown that D57, L58 and E92 residues are also part of epitopes. Jeannin et al. [42] have mentioned in their study that 118CQIYPPNVNKIREALAQ133 sequences might correspond to B-cell epitopes of Der p 1 which partially overlaps with the predicted epitope in our study (Y121–N126). They have also reported 188VRNSWTNWGDNGY201 as Der p 1 epitope.

    • Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies

      2014, Immunobiology
      Citation Excerpt :

      One of the major allergenic molecules of Dpt is the glycoprotein Der p 1, and some potential epitopes have been predicted by bioinformatic methods. Using a three-dimensional model, Der p 1 (222-amino acids based protein) has been mapped, four potential B cell epitopes have been selected and their IgE-dependent biological activities demonstrated (Greene and Thomas 1992; Jeannin et al. 1992; Duez et al. 2001). One of these epitopes (peptide p52-71) was used as a model epitope in the present study.

    • Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen

      2006, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      Located 14 Å from the catalytic site, Mg++ is unlikely to play a major role, if any, in Der p 1 activity, as confirmed by maintenance of peptidolytic activity in presence of EDTA (data not shown), but its location close to the allergen surface could alter or stabilize the conformation of IgE epitopes, including the 52-56 stretch (Fig 3, D). Such epitopes have been described.10 Interestingly, in the Der p 1.0110 isoform, Glu 44 is replaced by an Asp (see this article's Table E2 in the Online Repository at www.jacionline.org).

    • Molecular biology of allergens

      1996, Immunology and Allergy Clinics of North America
    View all citing articles on Scopus
    View full text